Jazz Pharmaceuticals plc — Director's Dealing 2019

Mar 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-03-05

Reporting Person: McGill Iain (SVP, Europe & Rest of World)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-05	Ordinary Shares	F	549	$135.82	Disposed	25556	Direct
2019-03-05	Ordinary Shares	F	618	$135.82	Disposed	24938	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.